Digitalising insecticide-treated net distribution to improve the accuracy of data collection and allow real-time data use is yielding promising results in South Sudan and Nigeria, according to new research.
World leaders are meeting to address the growing global threat of antimicrobial resistance and form a united response against this multifaceted problem.
Increasing malaria surges in Ethiopia threaten to undo the progress that has been achieved against the disease over the past two decades. In response, the Ethiopian government has launched a comprehensive approach to combat these outbreaks.
In a world first, the Sanaria PfSPZ malaria vaccine has been shown to protect expectant mothers from malaria before and during pregnancy.
In another momentous step forward for child survival against malaria, Mozambique has become the 11th country to introduce a malaria vaccine. Last week, the first phase of the R21 vaccine rollout began in 22 districts of Zambézia province.
In a significant step forward in the global fight against malaria, Côte d’Ivoire and South Sudan have become the first countries to administer the new R21/Matrix-M malaria vaccine to children at risk. These groundbreaking initiatives mark a crucial moment in efforts to combat one of the world’s deadliest diseases.
In one of the first studies globally to explore the potential clinical interactions between COVID-19, long COVID and malaria infections, Malaria Consortium has completed participant enrolment and data collection for a pioneering study in Ethiopia and Uganda.
A recent study published in BMC Malaria Journal highlights the challenges faced by communities in accessing malaria services — including availability and cost of services — in conflict-affected regions of Cameroon. The…
Climate change and antimicrobial resistance will be prominent issues at the seventy-seventh World Health Assembly, taking place from 27 May to 1 June in Geneva.
The World Health Organization Task Team on Climate Change, in partnership with Reaching the Last Mile, has launched a critical review exploring the effects of climate change on malaria and 20 neglected tropical diseases (NTDs), and the potential impact of mitigation and adaptation strategies.
This week, Malaria Consortium’s team in Uganda and Chief Executive, Dr James Tibenderana, engaged in key discussions with Uganda’s Ministry of Health on partnership approaches to accelerate progress towards eliminating malaria in the country.
Malaria Consortium has been honoured for its groundbreaking efforts in malaria prevention, both within Uganda and internationally, at the annual World Malaria Day Scientific Colloquium 2024.
The UK-Africa Health Summit took place this week, uniting global health leaders in antimicrobial stewardship to tackle this increasing threat ahead of the 2024 High-level Meeting on antimicrobial resistance (AMR) in New York.
The fifth Annual Meeting of the Seasonal Malaria Chemoprevention (SMC) Alliance brought together implementing countries, partners and donors to review the past year’s activities and plan for future SMC campaigns across Africa.
New research finds that increasing the coverage of four pneumonia interventions to at least 90 percent from 2023 until 2030 could prevent half of the predicted deaths from pneumonia of children under five in Chad, Ethiopia and Bangladesh.
In a new collaboration, Malaria Consortium and eGov Foundation will support Mozambique’s National Malaria Control Programme (NMCP) to roll out a new digital tool to accelerate the digitalisation of seasonal malaria chemoprevention (SMC) campaigns.
The world’s first large-scale immunisation programme of the RTS,S malaria vaccine began today in 42 districts of Cameroon and is expected to deliver 662,000 doses. This marks a significant milestone in child health and the urgent fight against malaria, offering hope for the future for thousands of children.